ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

HVO Hvivo Plc

29.50
0.60 (2.08%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hvivo Plc LSE:HVO London Ordinary Share GB00B9275X97 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.60 2.08% 29.50 28.50 29.50 29.00 28.90 28.90 746,449 16:35:09
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 48.48M -776k -0.0011 -263.64 195.77M

hVIVO plc Directors' Dealings (9735J)

05/04/2018 12:00pm

UK Regulatory


Hvivo (LSE:HVO)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Hvivo Charts.

TIDMHVO

RNS Number : 9735J

hVIVO plc

05 April 2018

For immediate release 12.00pm: 5 April 2018

HVIVO PLC

("hVIVO" or the "Company")

Directors' Dealings

hVIVO plc (AIM: HVO), a specialty biopharma company with discovery and clinical testing capabilities, announces that application has been made to AIM for the admission of 18,595 new ordinary shares of 5.0p each in the Company (the "New Ordinary Shares").

The New Ordinary Shares have been allotted pursuant to the purchase by Jaime Ellertson (Non-Executive Chairman) and Jim Winschel (Non-Executive Director) of new ordinary shares, under the terms of their letters of appointment as set out in the Company's announcement of 4 November 2014 which stated that Mr Ellertson and Mr Winschel had entered into binding commitments to purchase $20,000 and GBP4,000 of hVIVO plc new ordinary shares respectively per quarter. On 7 June 2017 Jaime Ellertson volunteered to reduce his Director's fee by 10% to $180k pa, then on 13 November 2017 his role changed from Non-Executive Chairman to Non-Executive Director and his Director's fee reduced to GBP50k pa. His quarterly purchase of shares has reduced accordingly as 40% of his Director's fee.

The New Ordinary Shares represent their investments for the quarter ended 31 March 2018. On 4 April 2018, Mr Ellertson invested in an additional 10,331 ordinary shares and Mr Winschel invested in an additional 8,264 ordinary shares, at a price of 48.4 pence per share.

Following admission of the New Ordinary Shares to trading on AIM, the total number of ordinary shares with voting rights in issue will be 78,216,137 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

Admission of the New Ordinary Shares ("Admission"), which will rank pari passu in all respects with the Company's existing shares in issue, is expected to occur on 9 April 2018. Following Admission, Mr Ellertson and Mr Winschel will be interested in a total of 139,145 and 65,661 ordinary shares of 5.0p in the Company respectively, representing 0.2% and less than 0.1% of the Company's issued share capital.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail:

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1    Details of the persons discharging managerial responsibilities/persons 
       closely associated 
 a)   Name                        Jaime Ellertson and Jim Winschel 
     --------------------------  --------------------------------------------- 
 2    Reason for the notification 
     ------------------------------------------------------------------------- 
 a)   Position/                   Non-Executive Director 
       status 
     --------------------------  --------------------------------------------- 
 b)   Initial notification/       Initial Notification 
       Amendment 
     --------------------------  --------------------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ------------------------------------------------------------------------- 
 a)   Name                        hVIVO plc 
     --------------------------  --------------------------------------------- 
 b)   Legal Entity                N/A 
       Identifier 
     --------------------------  --------------------------------------------- 
 4    Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     ------------------------------------------------------------------------- 
 a)   Description                 Ordinary shares of 5 pence each 
       of the financial 
       instrument, 
       type of instrument          GB00B6ZM0X53 
 
       Identification 
       code 
     --------------------------  --------------------------------------------- 
 b)   Nature of                   Acquisition of ordinary shares 
       the transaction 
     --------------------------  --------------------------------------------- 
 c)   Currency                    GBP 
     --------------------------  --------------------------------------------- 
 d)   Price(s) and                    Director           Price (p)   Volume 
       volume(s)                      Jaime Ellertson    48.4        10,331 
                                                        ----------  ------- 
                                       Jim Winschel       48.4        8,264 
                                                        ----------  ------- 
     -------------------------- 
 
 e)   Aggregated 
       information 
       - Aggregated 
        volume 
       - Price                     18,595 
       - Aggregated                 48.4p 
        total 
                                    GBP8,999.98 
     --------------------------  --------------------------------------------- 
 f)   Date of the                 4 April 2018 
       transaction 
     --------------------------  --------------------------------------------- 
 g)   Place of the                London Stock Exchange, AIM 
       transaction 
     --------------------------  --------------------------------------------- 
 

For further information please contact:

 
 hVIVO plc                                  +44 207 756 1300 
 Kym Denny (Chief Executive Officer) 
 Graham Yeatman (Chief Financial & 
  Business Officer) 
 
 Media Enquiries                            +1 919 710 9658 
 Susan Flood (Head of Marketing) 
 
 Numis Securities Limited                   +44 207 260 1000 
 Michael Meade / Freddie Barnfield 
  (Nominated Adviser) 
 James Black / Michael Burke (Corporate 
  Broking) 
 
 FTI Consulting 
 Simon Conway / Victoria Foster Mitchell 
  (UK)                                      +44 203 727 1000 
 John Capodanno / Evan Smith (US)           +1 212 850 5705 
 

Notes to Editors:

hVIVO plc ("hVIVO") is pioneering a human-based analytical platform to accelerate drug discovery and development in respiratory and infectious diseases. Leveraging human disease models in flu, RSV and asthma exacerbation, the hVIVO platform captures disease in motion, illuminating the entire disease life cycle from healthy to sick and back to health. Based in the UK, market leader hVIVO has conducted more than 50 clinical studies, inoculated over 2500 volunteers and has three first-in-class therapies currently in development with a growing pre-clinical pipeline.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHUGURCCUPRGUA

(END) Dow Jones Newswires

April 05, 2018 07:00 ET (11:00 GMT)

1 Year Hvivo Chart

1 Year Hvivo Chart

1 Month Hvivo Chart

1 Month Hvivo Chart

Your Recent History

Delayed Upgrade Clock